PRESS STATEMENTS06.16.2020 Merck and Pfizer’s SGLT2 Inhibitor STEGLATROTM (ertugliflozin) Meets Primary Endpoint in VERTIS CV Trial for Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease05.28.2020 Corning and Pfizer Announce Supply Agreement for Corning Valor® Glass Packaging05.01.2020 Pfizer Receives Positive CHMP Opinion for DAURISMO® (glasdegib) for Certain Adult Patients with Newly Diagnosed or Secondary Acute Myeloid Leukemia (AML)03.02.2020 Pfizer Provides Comment on COVID-19 White House Meeting01.23.2020 Pfizer Brings Three New Biosimilars to U.S. Patients at Substantial Discounts11.15.2019 Pfizer Announces CHMP Opinion for XELJANZ® (tofacitinib) in the European Union Related to Ongoing Review of the Product10.18.2019 Pfizer Statement on Vincristine Sulfate Injection, USP Supply in the United States10.17.2019 Pfizer Statement on Results of Pay Equity Study and Opportunity Parity Among Colleagues Worldwide09.17.2019 TrialSpark and Pfizer collaborating to improve speed and access to clinical trials09.17.2019 Terry Bradshaw and Pfizer Educate Boomers About the Risks of Pneumococcal Pneumonia and the Importance of Vaccination09.12.2019 Catalia Health and Pfizer collaborate to better understand patient journeys using artificial intelligence and via robot wellness coach09.06.2019 Hospira, Inc., Issues A Voluntary Nationwide Recall for one lot of BACTERIOSTATIC WATER for Injection, USP, due to a Potential Lack of Sterility Assurance.09.01.2019 Findings Released from NAXOS, a French Real-World Data Analysis and the Largest Real-World Data Analysis on Oral Anticoagulant Effectiveness and Safety in Europe Among Patients with Non-Valvular Atrial Fibrillation08.14.2019 Pfizer Inc. Issues A Voluntary Nationwide Recall For 2 Lots of RELPAX® (eletriptan hydrobromide) 40 mg Tablets Due to Potential Microbiological Contamination of Non-Sterile Products07.26.2019 Pfizer Statement on Update to XELJANZ® (tofacitinib) Prescribing Information in the United States05.17.2019 Pfizer confirms initiation of EU review of Tofacitinib with interim recommendations04.26.2019 Pfizer Inc. Issues A Voluntary Nationwide Consumer Level Recall of One Lot of ThermaCare® Back Pain Therapy HeatWraps, up to 16HR pain relief, Due To Out of Specification Results for High Cell Temperature03.18.2019 Hospira, Inc. Issues A Voluntary Nationwide Recall of 8.4% Sodium Bicarbonate Injection, USP Due To The Presence of Particulate Matter.02.19.2019 Pfizer Announces Modification To Ongoing Tofacitinib FDA Post-Marketing Requirement Study In Patients With Rheumatoid Arthritis11.26.2018 Pfizer Inc. Issues A Voluntary Nationwide Consumer Level Recall Of Six Lots Of ThermaCare® HeatWraps Due To Leaking Wraps with the Potential For Skin InjuriesPaginationFirst page« FirstPrevious page‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6Next pageNext ›Last pageLast »Press Release ArchivePress StatementsPodcastsThe Antigen PodcastThe Antigen Podcast Season 1The Antigen Podcast Episode 1: Vaccines 101The Antigen Podcast Episode 2: The History of VaccinesThe Antigen Podcast Episode 3: Global Perspectives, Barriers & SolutionsThe Antigen Podcast Episode 4: Vaccine Hesitancy Part 1The Antigen Podcast Episode 5: Vaccine Hesitancy Part 2The Antigen Podcast Episode 6: Vaccine Politics, Policy & AdvocacyThe Antigen Podcast Episode 7: Innovations in the Vaccine LandscapeThe Antigen Podcast Episode 8: What's Next?The Antigen Podcast Season 2The Antigen Podcast Episode 1: #COVID19 Looking Back to Look ForwardThe Antigen Podcast Episode 2: #COVID19 What Do We Do in the Meantime?The Antigen Podcast Episode 3: #COVID19 The Quest for a VaccineThe Antigen Podcast Episode 4: #COVID19 Teamwork Makes the Dream WorkGet Science PodcastDiverse Perspectives Podcastmenopause: unmutedContact Media RelationsPress Kits & DownloadsCompany Press KitPfizer Oncology Press KitPSA NarrativeRA NarRAtiveRare Disease Gene Therapy Press KitATTR-Amyloidosis Press KitUC NarrativeEczema Inside Out Press KitOnline Pfizer Press KitCompany Press KitView the Pfizer Company Press KitPress StatementsView Pfizer's latest press statements Related ArticlesYour HealthLet’s Talk Osteoarthritis Pain: A Picture of Daily LifeOur ScienceThe Facts About Pfizer and BioNTech’s COVID-19 VaccineOur PeopleSandy Focuses on Diversity in Our Clinical TrialsOur PeopleAn Early Passion for Science and Public Health Inspires Adriana’…Our People“The Ice Man” - The Pfizer Colleague & Dad Who Keeps Our…Our ProductsDistributing Our COVID-19 Vaccine to the WorldOur PurposeThe Value of Vaccines in Disease Prevention: A Global PerspectiveOur PurposeThe Value of Vaccines in Disease Prevention in Latin AmericaYour HealthViral vs. Bacterial Pneumonia: Understanding the DifferenceOur ScienceNew Discoveries in Metastatic Breast Cancer Can’t Wait: How…Our PurposeAdvancing Health Equity & Social Justice Through Community…Your HealthIn Her Words: Jacklyn’s Life With Ulcerative ColitisYour HealthFeeling Sick? Use this Symptom Checker for Common Fall and…Your HealthEczema and Stress: What's the Link?Our ScienceAlbert Bourla Discusses Our FDA SubmissionOur ScienceOur COVID-19 Vaccine Study – What’s Next?Your HealthCOVID-19 Vaccine U.S. Distribution Fact SheetYour HealthWhy Your Family Health History MattersYour HealthWhy You Need Your Workout Now More Than EverOur PurposePartnering for Sustainable Solutions: Combatting the Deadly…Your HealthChronic Stress and How to Manage ItShowHide
